SETDB1 Antibody

1. Study in hepatocellular carcinoma (HCC) cells proves that SETDB1 promotes the proliferation and migration of cells by forming SETDB1-Tiam1 compounds. SETDB1-Tiam1 compounds were involved in a novel pathway, which regulated epigenetic modification of gene expression in HCC patients samples. PMID: 29739365
2. SETDB1 loss results in decompaction of the Xi chromosome partly through reactivation of an enhancer in the IL1RAPL1 gene. PMID: 30103804
3. SETDB1 knockdown might suppress breast cancer progression at least partly by miR-381-3p-related regulation, providing a novel prospect in breast cancer therapy. PMID: 30309377
4. Enhancer of Zeste Homolog 2 (EZH2), SET domain, bifurcated 1 protein (SETDB1), lysine-specific histone demethylase 1 (LSD1), histone H3 methylation (H3K9me3 and H3K27me3) expression are altered in colorectal cancer (CRC) and may play a role in colorectal carcinogenesis. PMID: 30105513
5. Increased expression of SETDB1 may predict poor overall survival. PMID: 29901162
6. SETDB1 is enriched at H3K9me3 regions and K9me3/K14ac is enriched at SETDB1 binding sites overlapping with LINE elements, suggesting that recruitment of the SETDB1 complex to K14ac/K9me regions has a role in silencing of active genomic regions. PMID: 29234025
7. these data identify a critical functional role for ATF7IP in heterochromatin formation by regulating SETDB1 abundance in the nucleus. PMID: 27732843
8. SETDB1 triggers silencing of retrotransposons to inhibit the interferon response in acute myeloid leukemia cells. PMID: 28887438
9. analysis of a 1q21.3 deletion encompassing SETDB1 that provides further support for the role of chromatin modifiers in the etiology of autism spectrum disorder PMID: 27119313
10. SETDB1 protein expression was significantly associated with poor survival and was related to TNM stage. PMID: 28913972
11. SETDB1, a major histone H3K9 methyltransferase is monoubiquitinated at the evolutionarily conserved lysine-867 in its SET-Insertion domain. This ubiquitination is directly catalyzed by UBE2E family of E2 enzymes in an E3-independent manner while the conjugated-ubiquitin (Ub) is protected from active deubiquitination. PMID: 27237050
12. These results suggest that the ubiquitination of SETDB1 at lysine 867 controls the expression of its target gene by activating its H3K9 methyltransferase activity. PMID: 27798683
13. s observed several complementary mechanisms contributing to the upregulation of SETDB1 in HCC cells. Besides copy number gains at the SETDB1 gene locus at chromosome 1q21 enhanced SETDB1 transcription mediated by the transcription factor SP1 could be detected. PMID: 27164857
14. BRCA1 and SETDB1 stand out as the most significant prognostic markers in this group of patients PMID: 26542178
15. These results suggest that SETDB1- mediated FosB expression is a common molecular phenomenon, and might be a novel pathway responsible for the increase in cell proliferation that frequently occurs during anticancer drug therapy. PMID: 26949019
16. SETDB1 mutations are associated with malignant pleural mesotheliomas. PMID: 26824986
17. Upon HBV infection, cellular mechanisms involving SETDB1-mediated H3K9me3 and HP1 induce silencing of HBV cccDNA transcription through modulation of chromatin structure. PMID: 26143443
18. The SETDB1 protein was closely associated with the prognosis of prostate cancer (PCa). Bioinformatics suggested that SETDB1 might promote PCa bone metastasis through the WNT pathway. In conclusion, SETDB1 might be associated with the development of bone metastases from PCa PMID: 26846621
19. results indicate that ATF7IP does not directly modulate SETDB1 catalytic activity, suggesting alternate roles, such as affecting cellular localization or mediating interaction with additional binding partners. PMID: 26813693
20. SETDB1 is an oncogene that is frequently up-regulated in human HCCs; the multiplicity of SETDB1 activating mechanisms at the chromosomal, transcriptional, and posttranscriptional levels together facilitates SETDB1 up-regulation in human HCC PMID: 26481868
21. regulates cancer cell growth via methylation of p53 PMID: 26471002
22. SETDB1, localized in the nucleus, might undergo degradation by the proteasome and be exported to the cytosol, resulting in its detection mainly in the cytosol. PMID: 26296461
23. Exogenous expression of MyoD reversed transcriptional repression of MyoD promoter-driven lucif-erase reporter by Setdb1 shRNA and rescued myogenic differentiation of C2C12 myoblast cells depleted of endogenous Setdb1. PMID: 25715926
24. s demonstrate that a KMT1E-containing complex directly interacts with the FcgammaRIIb promoter and that histone H3 at lysine 9 tri-methylation at this promoter is dependent on Setdb1 PMID: 25569264
25. MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the Epithelial-mesenchymal transition of breast cancer stem cells by down regulating the STAT3 pathway PMID: 25070049
26. Report elevated levels of SETDB1 in non-small lung cancers, associated with neoplasm grading and tumor growth. PMID: 25404354
27. This observation suggests that the ZNF274/SETDB1 complex bound to the SNORD116 cluster may protect the Prader-Willi syndrome induced pluripotent cells from DNA demethylation during early development. PMID: 24760766
28. Together, our findings defined an essential role for the KMT1E/SMAD2/3 repressor complex in TGFbeta-mediated lung cancer metastasis. PMID: 25477335
29. SETDB1 is associated with frequent methylation of the euchromatic p16(INK) (4A) promoter and several prognostic parameters in melanomas PMID: 24673285
30. data suggested that SETDB1 is overexpressed in human PCa. Silencing SETDB1 inhibited PCa cell proliferation, migration and invasion PMID: 24556744
31. overexpression of SETDB1 or LSD1 had no prognostic impact in patients with melanoma PMID: 24658378
32. SETDB1 expression was upregulated in glioma cell lines and in glioma tissues compared to normal brain, being positively correlated with grade and histological malignancy. PMID: 23943221
33. SETDB1 is a bona fide oncogene undergoing gene amplification-associated activation in lung cancer. PMID: 23770855
34. of ESET plays an essential role in the maintenance of articular cartilage by preventing articular chondrocytes from terminal differentiation and may have implications in joint diseases such as osteoarthritis. PMID: 24056368
35. A transgenic Setdb1 model established a link between this gene and behavior. PMID: 23055267
36. analysis of a KRAB domain-containing ZNF (ZNF274) that is involved in recruitment of the KAP1 and SETDB1 to specific regions of the human genome PMID: 21170338
37. studies establish SETDB1 as an oncogene in melanoma and underscore the role of chromatin factors in regulating tumorigenesis PMID: 21430779
38. Contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins; KAP-1, SETDB1, H3-MeK9, and HP1 are enriched at promoter sequences of a euchromatic gene silenced by the KRAB-KAP-1 repression system PMID: 11959841
39. mAM/hAM facilitates conversion of H3-K9 dimethyl to trimethyl by ESET/SETDB1 PMID: 14536086
40. Data show that the methyl-CpG binding protein MBD1 forms a stable complex with histone H3-K9 methylase SETDB1. PMID: 15327775
41. These data suggest that MBD1.MCAF1.SETDB1 complex facilitates the formation of heterochromatic domains, emphasizing the role of MCAF/AM family proteins in epigenetic control, and describe a new family member, MCAF2 (ATF7IP2). PMID: 15691849
42. histone methyltransferase SETDB1 and the DNA methyltransferase DNMT3A interact directly and localize to promoters silenced in cancer cells PMID: 16682412
43. modulation of gene silencing mechanisms, through regulation of the ESET gene is important to neuronal survival and, as such, may be a promising treatment in Huntington's disease patients PMID: 17142323
44. Akt/PKB interacts with the histone H3 methyltransferase SETDB1 and coordinates to silence gene expression. PMID: 17577629
45. SETDB1 can specifically methylate HIV-1 Tat preferentially at lysine 51. PMID: 18498648

显示更多

收起更多

HGNC: 10761

OMIM: 604396

KEGG: hsa:9869

STRING: 9606.ENSP00000271640

UniGene: Hs.643565